FLAGSTAFF, Ariz., Sept. 26, 2019 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today its further expansion into the organic products industry with the addition of ContraPest® for rodent control at Captain Vineyards.
"The organic industry is a natural part of our broader food and agriculture strategy," said Kenneth Siegel, SenesTech's CEO. "As with their conventional counterparts, organic facilities have struggled with rodent management and are looking for effective solutions. ContraPest, either alone or as part of a broader integrated pest management program, offers them a new alternative that will reduce both product loss and contamination risk. We are excited that the organic industry is responding to our poison-free solution."
"At Captain Vineyards, as the first and only green winery in Contra Costa County, we take pride in every step of our production process: energy conservation, dry farming, zero waste and reduced carbon footprint. The addition of ContraPest in our integrated pest management plan is an obvious fit," said Sal Captain, owner and winemaker. "Further, we are pleased to introduce ContraPest to our community of vineyards and others committed to sustainability."
Dr. Loretta P. Mayer, SenesTech's co-founder and Chief Scientific Officer, added, "We are pleased with the reception we are receiving from the organic food industry of California. They are welcoming our commitment to provide them with a product that meets their need for an effective and sustainable solution in pest management that is consistent with their values."
SenesTech is changing the paradigm of pest management by targeting the root cause of the problem: reproduction.
ContraPest® is an innovative technology with an approach that targets the reproductive capabilities of both sexes in rat populations, inducing egg loss in female rats and impairing sperm development in males. Using a proprietary bait delivery method, ContraPest® is dispensed in a highly palatable liquid formulation that promotes sustained consumption by rat communities. ContraPest® is designed, formulated and dispensed to be low hazard for handlers and non-target species such as wildlife, livestock and pets, where the active ingredients break down rapidly.
We believe ContraPest® will establish a new paradigm in rodent control, resulting in a decreased reliance on lethal options. For more information visit the SenesTech website at www.senestech.com.
Safe Harbor Statement
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors and other risks identified in our filings with the Securities and Exchange Commission. Forward looking statements include, but are not limited to, our expectation regarding sales commitments, our expectation regarding the conversion of sales commitments and programs to revenue, our belief that our product is more humane, less harmful to the environment and more effective than traditional methods, and our belief that ContraPest will establish a new paradigm in rodent control without environmental effects of rodenticides. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.
Investor: Robert Blum, Joe Dorame, Joe Diaz, Lytham Partners, LLC, 602-889-9700, firstname.lastname@example.org
Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., 928-779-4143
SOURCE SenesTech, Inc.